Oral Adjuvant Chemotherapy with S-1 or Uracil-tegafur versus Surgery Alone in Patients with Biliary Tract Cancer

MLA

Osamu Itano, et al. “Oral Adjuvant Chemotherapy with S-1 or Uracil-Tegafur versus Surgery Alone in Patients with Biliary Tract Cancer.” Chemotherapy: Open Access, Jan. 2015. EBSCOhost, https://doi.org/10.4172/2167-7700.1000174.

APA

Osamu Itano, Naokazu Chiba, Taizo Hibi, Hiroshi Yagi, Masahiro Shinoda, Motohide Shimazu, Yuta Abe, Yuko Kitagawa, Minoru Kitago, & Masatsugu Ishii. (2015). Oral Adjuvant Chemotherapy with S-1 or Uracil-tegafur versus Surgery Alone in Patients with Biliary Tract Cancer. Chemotherapy: Open Access. https://doi.org/10.4172/2167-7700.1000174

Chicago

Osamu Itano, Naokazu Chiba, Taizo Hibi, Hiroshi Yagi, Masahiro Shinoda, Motohide Shimazu, Yuta Abe, Yuko Kitagawa, Minoru Kitago, and Masatsugu Ishii. 2015. “Oral Adjuvant Chemotherapy with S-1 or Uracil-Tegafur versus Surgery Alone in Patients with Biliary Tract Cancer.” Chemotherapy: Open Access, January. doi:10.4172/2167-7700.1000174.